各イベント詳細
イベント一覧へ戻る

Catalyst for Pharmaceutical External R&D

13 Feb 2019
Information for our guests:

Title Catalyst for Pharmaceutical External R&D
Date Wed, 13-Feb-2019
Start 12:00
End 14:00
Venue Tokyo American Club
Hall/ Room Brooklyn 2&3
Address 2-1-2, Azabudai, Minato-ku, Tokyo 106-8649
Guests Fee (Yen) 7,900
Committees Healthcare. Digital Health. Medical Devices and Diagnostics. Regenerative Medicine and Biosciences. Pharmaceuticals.
Speaker(s) Dr. BT Slingsby (CEO & Executive Director GHIT Fund).
Registration Deadline Thu, 07-Feb-2019 12:00

Information source: http://www.accj.or.jp/accj-events

Dr. BT Slingsby will give his insights, experiences, and lessons learned as a catalyst for public private partnership (PPP) and external R&D, and provide a view on how this model can be applied to other areas where there is a need of new innovations.

Dr. Slingsby is a founding CEO of the Global Health Innovative Technology Fund (GHIT), the world's first PPP fund for global health R&D. GHIT was established in 2013 as an international PPP between Japanese pharmaceutical companies, the Bill and Melinda Gates Foundation, and two Japanese ministries.

GHIT’s innovative financing model was conceived and institutionalized by the private sector’s leadership, and GHIT has catalyzed open innovation between Japanese and global entities to create life saving medicines through its investment. Utilizing not only internal but also external R&D resources is becoming an increasingly significant trend in pharmaceutical industry to drive innovations.
イベント一覧へ戻る
[メインページへ]
Copyright(C) MedicaLingual Inc. All Rights Reserved.
本サイトの文章・画像の無断転用、転写はご遠慮下さい。